338
Participants
Start Date
September 30, 2006
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
Quetiapine
Research Site, Birmingham
Research Site, San Diego
Research Site, Fort Myers
Research Site, Gainsville
Research Site, Sarasota
Research Site, Roswell
Research Site, Boston
Research Site, Brooklyn
Research Site, Eugene
Research Site, Jenkintown
Research Site, Memphis
Research Site, Austin
Research Site, San Antonio
Research Site, City Bell
Research Site, La Plata
Research Site, Córdoba
Research Site, Mendoza
Research Site, Buenos Aires
Research Site, Capital Federal
Research Site, Tartu
Research Site, Tallinn
Research Site, Viljandi
Research Site, Helsinki
Research Site, Tampere
Research Site, Järvenpää
Research Site, Kuopio
Research Site, Salo
Research Site, Seinäjoki
Research Site, Arkhangelsk
Research Site, Izhevsk
Research Site, Lipetsk
Research Site, Moscow
Research Site, Nizhny Novgorod
Research Site, Perm
Research Site, Saint Petersburg
Research Site, Stavropol
Research Site, Hlevakha
Research Site, Dnipropetrovsk
Research Site, Donetsk
Research Site, Kiev
Research Site, Luhansk
Research Site, Odesa
Research Site, Vinnitsa
Lead Sponsor
AstraZeneca
INDUSTRY